Clinical trials in Rochester, MN

206 recruiting studies have a site in or near Rochester, MN, Minnesota.

Top conditions here

All conditions

Showing 40 of 206 studies

RecruitingPhase 3NCT04047628

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Minneapolis, MN · Rochester, MN · +21 more sites

RecruitingPhase 1NCT07103018

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Sponsor: K36 Therapeutics, Inc.

Rochester, MN · +12 more sites

RecruitingPhase 3NCT03150693

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Sponsor: Alliance for Clinical Trials in Oncology

Aitkin, MN · Brainerd, MN · Burnsville, MN · +452 more sites

RecruitingPhase 3NCT04267848

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Sponsor: National Cancer Institute (NCI)

Aitkin, MN · Bemidji, MN · Brainerd, MN · +1147 more sites

RecruitingPhase 4NCT06972056

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

Sponsor: Mayo Clinic

Rochester, MN · +36 more sites

RecruitingPhase 2NCT06976619

The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes

Sponsor: Mayo Clinic

Rochester, MN

RecruitingPhase 3NCT07190209

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Sponsor: Sanofi

Rochester, MN · +74 more sites

RecruitingNot applicableNCT06423430

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Sponsor: Abbott Medical Devices

Minneapolis, MN · Rochester, MN · +24 more sites

RecruitingPhase 1 / Phase 2NCT06810544

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Sponsor: Tango Therapeutics, Inc.

Rochester, MN · +14 more sites

RecruitingPhase 1NCT06879041

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

Sponsor: AstraZeneca

Rochester, MN · +11 more sites

RecruitingPhase 1 / Phase 2NCT06973564

JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

Sponsor: Jacobio Pharmaceuticals Co., Ltd.

Rochester, MN · +3 more sites

RecruitingPhase 3NCT06170788

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Sponsor: Merck Sharp & Dohme LLC

Minneapolis, MN · Rochester, MN · +13 more sites

RecruitingNot applicableNCT07005050

Renal Pelvic Denervation Pilot Trial

Sponsor: Verve Medical, Inc

Minneapolis, MN · Rochester, MN · +7 more sites

RecruitingNot applicableNCT06325046

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

Sponsor: Mayo Clinic

Albert Lea, MN · Mankato, MN · Rochester, MN · +2 more sites

RecruitingPhase 3NCT06935370

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Sponsor: Boehringer Ingelheim

Minneapolis, MN · Rochester, MN · Saint Paul, MN · +86 more sites

RecruitingNot applicableNCT04101669

The RESET System Pivotal Clinical Trial (Protocol Revision K)

Sponsor: Morphic Medical Inc.

Rochester, MN · +26 more sites

RecruitingPhase 3NCT06430801

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Sponsor: Merck Sharp & Dohme LLC

Rochester, MN · +86 more sites

RecruitingNot applicableNCT06511141

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Sponsor: Axonics, Inc.

Rochester, MN · +22 more sites

RecruitingPhase 3NCT06989112

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Sponsor: AstraZeneca

Marshall, MN · Minneapolis, MN · Rochester, MN · +60 more sites

RecruitingPhase 3NCT07088068

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

Sponsor: Sanofi

Rochester, MN · Saint Louis Park, MN · +32 more sites

RecruitingPhase 2NCT07023289

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Sponsor: AbbVie

Minneapolis, MN · Rochester, MN · +20 more sites

RecruitingPhase not listedNCT07868614

Intraoperative Microelectrode Recordings Using MAVEN Compared to Standard Recording Apparatuses

Sponsor: Mayo Clinic

Rochester, MN

RecruitingPhase 3NCT03678025

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Sponsor: SWOG Cancer Research Network

Coon Rapids, MN · Edina, MN · Fridley, MN · +331 more sites

RecruitingPhase 3NCT07174336

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Sponsor: Eli Lilly and Company

Minneapolis, MN · Rochester, MN · Saint Louis Park, MN · +126 more sites

RecruitingPhase 3NCT07222800

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Sponsor: Pfizer

Marshall, MN · Rochester, MN · +251 more sites

RecruitingPhase 1NCT07311993

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

Sponsor: Cellectar Biosciences, Inc.

Rochester, MN · +3 more sites

RecruitingPhase 2NCT07415044

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Sponsor: Eli Lilly and Company

Rochester, MN · +51 more sites

RecruitingPhase 2NCT07589595

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Sponsor: Eli Lilly and Company

Golden Valley, MN · Rochester, MN · +40 more sites

RecruitingPhase 1 / Phase 2NCT05919264

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Sponsor: Parabilis Medicines, Inc.

Minneapolis, MN · Rochester, MN · +29 more sites

RecruitingNot applicableNCT06424015

Insulin and Insulin Pulses During Fasting

Sponsor: Mayo Clinic

Rochester, MN

RecruitingPhase 3NCT06672549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Sponsor: Eli Lilly and Company

Minneapolis, MN · Rochester, MN · Saint Paul, MN · +47 more sites

RecruitingPhase 1 / Phase 2NCT06710756

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Sponsor: Perspective Therapeutics

Rochester, MN · +15 more sites

RecruitingPhase 3NCT06997497

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Sponsor: Merck Sharp & Dohme LLC

Rochester, MN · +47 more sites

RecruitingPhase not listedNCT07143669

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Sponsor: Blueprint Medicines Corporation

Rochester, MN · +24 more sites

RecruitingPhase 1NCT05091424

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Sponsor: Hoffmann-La Roche

Rochester, MN · +4 more sites

RecruitingNot applicableNCT05427370

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

Sponsor: Sunnybrook Health Sciences Centre

Rochester, MN · +5 more sites

RecruitingPhase 2NCT07012395

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Sponsor: Spyre Therapeutics, Inc.

Rochester, MN · +25 more sites

RecruitingPhase 2NCT07492680

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Sponsor: Bristol-Myers Squibb

Rochester, MN · +13 more sites

RecruitingPhase 2NCT06570798

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

Sponsor: Amgen

Rochester, MN · +17 more sites

RecruitingNot applicableNCT03523416

Early Feasibility Study - Edwards APTURE Transcatheter Shunt System

Sponsor: Edwards Lifesciences

Minneapolis, MN · Rochester, MN · +17 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.